stars 1 stars 2 stars 3

Headquartered in Birmingham, Ala., CIRCULOGENE is an innovative molecular diagnostics company founded and operated by a team of experienced industry executives and skilled molecular diagnostics scientists. Applying its proprietary laboratory developed test for cfDNA, cfRNA and MSI liquid biopsies, CIRCULOGENE has developed a next-generation sequencing (NGS) method to provide full genomic load analysis from one standard tube of blood in one week, enabling more accurate data to help clinicians and their patients choose targeted therapies, monitor efficacy and monitor for recurrence. One tube, one week, complete results. Somatic + Germline; Blood + Tissue + Buccal; DNA + RNA + MSI + PD-L1. CONTACT info@circulogene.com For Asia Pacific inquiries, please email AsiaPacfic@circulogene.com For Middle Eastern inquiries, please email Irem.Agin@circulogene.com.tr

CIRCULOGENE Questions

The CIRCULOGENE annual revenue was $2 million in 2026.

Michael Mullen is the Chairman and CEO of CIRCULOGENE.

33 people are employed at CIRCULOGENE.

CIRCULOGENE is based in Birmingham, Alabama.

The NAICS codes for CIRCULOGENE are [54171, 54, 541713, 541, 5417].

The SIC codes for CIRCULOGENE are [87, 873].

Top CIRCULOGENE Employees

View Similar People
G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users